Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))31.5.2023R
 31.5.2023Sandoz GmbH (SAN-A)4594BPregabalin Sandoz 75 mg tvrdé kapsuly (cps dur 56x1x75 mg (blis.PVC/PVDC/Al-perf.))31.5.2023O
 31.5.2023Sandoz GmbH (SAN-A)49549Ospen 400 (sir 1x150 ml (fľ.skl.tmavá))31.5.2023O
 31.5.2023Sandoz GmbH (SAN-A)65489Zarzio 48 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke (sol ijf 5x0,5 ml/48 MU (striek.inj.skl.napln. s ochr.krytom ihly))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)00530Amoksiklav 1000 mg granulát na perorálnu suspenziu (gru por 12x(875 mg+125 mg) (vre.papier/PE/Al/PE))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2201CCalcium folinate Sandoz 10 mg/ml (sol ijf 1x10 ml/100 mg (liek.inj.skl.jantárová))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2203CCalcium folinate Sandoz 10 mg/ml (sol ijf 1x35 ml/350 mg (liek.inj.skl.jantárová))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)30446LEKOKLAR 250 mg/5 ml granulát na perorálnu suspenziu (gru por 1x100 ml (68,3 g gran./57,0 ml vody) (fľ.HDPE))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)33218Amoksiklav 2x457 mg/5 ml (plu por 1x35 ml (fľ.skl.jantárová+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)33219Amoksiklav 2x457 mg/5 ml (plu por 1x70 ml (fľ.skl.jantárová+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5782AVorikonazol Sandoz 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/PVDC/Al))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)58702TAMOXIFEN Sandoz 20 mg (tbl 100x20 mg (liek.PP))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7569BEplerenon Sandoz 25 mg filmom obalené tablety (tbl flm 90x25 mg (blis.PVC/Al))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89132PERINDASAN 4 mg/1,25 mg tablety (tbl 90x4 mg/1,25 mg (blis.Al/Al))31.5.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9739BAlopurinol Sandoz 300 mg (tbl 30x300 mg (blis.PVC/Al))31.5.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)